BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15459303)

  • 1. Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma.
    Clementi R; Dagna L; Dianzani U; Dupré L; Dianzani I; Ponzoni M; Cometa A; Chiocchetti A; Sabbadini MG; Rugarli C; Ciceri F; Maccario R; Locatelli F; Danesino C; Ferrarini M; Bregni M
    N Engl J Med; 2004 Sep; 351(14):1419-24. PubMed ID: 15459303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune lymphoproliferative syndrome and perforin.
    Rieux-Laucat F; Le Deist F; De Saint Basile G
    N Engl J Med; 2005 Jan; 352(3):306-7; author reply 306-7. PubMed ID: 15659737
    [No Abstract]   [Full Text] [Related]  

  • 3. Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function.
    Clementi R; Chiocchetti A; Cappellano G; Cerutti E; Ferretti M; Orilieri E; Dianzani I; Ferrarini M; Bregni M; Danesino C; Bozzi V; Putti MC; Cerutti F; Cometa A; Locatelli F; Maccario R; Ramenghi U; Dianzani U
    Blood; 2006 Nov; 108(9):3079-84. PubMed ID: 16720836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.
    Cerutti E; Campagnoli MF; Ferretti M; Garelli E; Crescenzio N; Rosolen A; Chiocchetti A; Lenardo MJ; Ramenghi U; Dianzani U
    BMC Immunol; 2007 Nov; 8():28. PubMed ID: 17999750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
    Del-Rey M; Ruiz-Contreras J; Bosque A; Calleja S; Gomez-Rial J; Roldan E; Morales P; Serrano A; Anel A; Paz-Artal E; Allende LM
    Blood; 2006 Aug; 108(4):1306-12. PubMed ID: 16627752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in apoptosis genes: a pathogenetic factor for human disease.
    Müllauer L; Gruber P; Sebinger D; Buch J; Wohlfart S; Chott A
    Mutat Res; 2001 Jul; 488(3):211-31. PubMed ID: 11397650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis.
    Pensati L; Costanzo A; Ianni A; Accapezzato D; Iorio R; Natoli G; Nisini R; Almerighi C; Balsano C; Vajro P; Vegnente A; Levrero M
    Gastroenterology; 1997 Oct; 113(4):1384-9. PubMed ID: 9322534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
    Rieux-Laucat F; Blachère S; Danielan S; De Villartay JP; Oleastro M; Solary E; Bader-Meunier B; Arkwright P; Pondaré C; Bernaudin F; Chapel H; Nielsen S; Berrah M; Fischer A; Le Deist F
    Blood; 1999 Oct; 94(8):2575-82. PubMed ID: 10515860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
    Straus SE; Jaffe ES; Puck JM; Dale JK; Elkon KB; Rösen-Wolff A; Peters AM; Sneller MC; Hallahan CW; Wang J; Fischer RE; Jackson CE; Lin AY; Bäumler C; Siegert E; Marx A; Vaishnaw AK; Grodzicky T; Fleisher TA; Lenardo MJ
    Blood; 2001 Jul; 98(1):194-200. PubMed ID: 11418480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune lymphoproliferative syndrome: types I, II and beyond.
    Chun HJ; Lenardo MJ
    Adv Exp Med Biol; 2001; 490():49-57. PubMed ID: 11505974
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease.
    Peters AM; Kohfink B; Martin H; Griesinger F; Wörmann B; Gahr M; Roesler J
    Exp Hematol; 1999 May; 27(5):868-74. PubMed ID: 10340403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations.
    Poppema S; Maggio E; van den Berg A
    Leuk Lymphoma; 2004 Mar; 45(3):423-31. PubMed ID: 15160902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proportion of patients with lymphoma may harbor mutations of the perforin gene.
    Clementi R; Locatelli F; Dupré L; Garaventa A; Emmi L; Bregni M; Cefalo G; Moretta A; Danesino C; Comis M; Pession A; Ramenghi U; Maccario R; Aricò M; Roncarolo MG
    Blood; 2005 Jun; 105(11):4424-8. PubMed ID: 15728124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients.
    Campagnoli MF; Garbarini L; Quarello P; Garelli E; Carando A; Baravalle V; Doria A; Biava A; Chiocchetti A; Rosolen A; Dufour C; Dianzani U; Ramenghi U
    Haematologica; 2006 Apr; 91(4):538-41. PubMed ID: 16537120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency.
    Ströbel P; Nanan R; Gattenlöhner S; Müller-Deubert S; Müller-Hermelink HK; Kreth HW; Marx A
    Am J Surg Pathol; 1999 Jul; 23(7):829-37. PubMed ID: 10403307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAS gene mutation in a case of autoimmune lymphoproliferative syndrome type IA with accumulation of gammadelta+ T cells.
    van den Berg A; Tamminga R; de Jong D; Maggio E; Kamps W; Poppema S
    Am J Surg Pathol; 2003 Apr; 27(4):546-53. PubMed ID: 12657942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
    Ramenghi U; Bonissoni S; Migliaretti G; DeFranco S; Bottarel F; Gambaruto C; DiFranco D; Priori R; Conti F; Dianzani I; Valesini G; Merletti F; Dianzani U
    Blood; 2000 May; 95(10):3176-82. PubMed ID: 10807785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune lymphoproliferative syndrome: molecular diagnosis in two families].
    Cambronero R; Cámara C; López-Granados E; Ferreira A; Fontán G; García Rodríguez MC
    Med Clin (Barc); 2003 May; 120(16):622-5. PubMed ID: 12732128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perforin: more than just an effector molecule.
    Stepp SE; Mathew PA; Bennett M; de Saint Basile G; Kumar V
    Immunol Today; 2000 Jun; 21(6):254-6. PubMed ID: 10825735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.